ESG

With new SAFE financing, Cubit Diagnostics advances its all-in-one molecular and immunoassay platform, aiming to revolutionize point-of-care STI testing.

With its new CCO, the AI health-tech firm aims to commercialize its patient-data platform, tackling billion-dollar delays in drug development.

The Italian pharma giant appoints a global health policy heavyweight, signaling a strategic pivot towards tackling complex global challenges and a new era.

With key leadership hires, Hudson Valley Property Group is scaling up to meet soaring investor demand for impact-driven affordable housing preservation.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

A massive $250M investment could replace a 40-pill daily burden with a single tablet for patients with pancreatic insufficiency, disrupting a market in crisis.

A new survey finds most mothers reject the 'routine' label, feeling strong in daily acts. One FemTech firm is now championing a shift from sacrifice to celebration.

From the makers of the 'World's Best Tequila,' a new Reposado redefines aging with a unique blend of Sauternes, Sherry, and Bourbon casks.

Seattle nonprofit Ryther launches Juniper, an intensive program for teens, addressing a critical gap in care for older adolescents with mood and anxiety.

A five-year exclusive deal for MilliporeSigma to test Genetix's gene therapies is set to ensure safety and expand access to one-time cures for rare diseases.

A historic UN petition reframes the Xinjiang crisis, accusing China of colonialism and demanding decolonization for East Turkistan after years of failed diplomacy.

A leading scientific body is ditching 'longevity' for 'geroscience,' aiming to bring scientific rigor to a field rife with hype and misinformation.

Chicago Atlantic posts stable Q1 distributable earnings but a sharp drop in net income due to credit provisions, banking on a cannabis rescheduling windfall.

With backing from an NBA owner, snacking dough brand Doich hires a new COO to lead its push into major grocery chains and the 'better-for-you' market.

As Texas booms, Oncor is spending billions on the grid. Find out how the state's economic expansion will directly impact the cost of your electricity.

A new drug shows major promise for a painful heart condition, with pivotal study results accepted by a top journal and a final-stage trial speeding ahead.

An unlikely alliance of sheriffs, tech experts, and justice-impacted leaders is forging a new path to reduce recidivism and solve labor shortages.

A landmark clinical trial suggests a different form of folate may be better for pregnancy, reducing a controversial byproduct without sacrificing key benefits.

As REX American Resources prepares for a key investor conference, its major bet on carbon capture technology is under the microscope. Will it pay off?

Quebec biotech firm Aplantex secures $5M to scale its unique green technology, moving from research to industrial production of sustainable ingredients.